Most human cancers are aneuploid, due to a chromosomal instability (CIN) phenotype. Despite being a hallmark of cancer, however, it is unclear what the impact is of CIN on tumor formation. Using a novel conditional mouse model for diverse degrees of CIN, we find that a particular range is sufficient to drive early onset tumor formation in the intestine. In mice predisposed to intestinal cancer (Apc Min/+ ), moderate and high CIN cause remarkable increases in tumor burden of the distal colon, resembling human disease. By contrast, in the same mice, high CIN has no impact on tumor formation in the small intestine. Correspondingly, colonic crypts of high CIN mice at the time of tumor initiation more readily maintain aberrant proliferative cells than those of the small intestine. Our results thus show that at a narrow range, and depending on the particular tissue setting, CIN can be potently oncogenic.
INTRODUCTION
Aneuploidy -an abnormal number of chromosomes -is a hallmark of human tumors (Lengauer et al., 1998) . While during embryogenesis almost all aneuploidies are lethal (Cohen, 2002) and aneuploidy levels in normal tissues are very low (Knouse et al., 2014) , chromosomal aberrations are observed in 70-90% of solid tumors Heim and Mitelman, 2010) . Aneuploidy is the result of chromosomal instability (CIN): the occasional gain or loss of whole chromosomes during mitosis. CIN can lead to genome destabilization (Bunting and Nussenzweig, 2013; Crasta et al., 2012; Janssen et al., 2011; Stephens et al., 2011) , and is associated with high intra-tumoral genomic heterogeneity, immune evasion, and promotion of metastases (reviewed in (Turajlic et al., 2019) ). Furthermore, CIN and aneuploidy are correlated with tumor aggressiveness, therapy resistance and poor patient prognosis Carter et al., 2006; Choi et al., 2009; Lee et al., 2011; McClelland et al., 2009; Orsetti et al., 2014; Roylance et al., 2011; Walther et al., 2008) .
One example of a very common and deadly cancer type that has a high prevalence of CIN and aneuploidy is colorectal cancer (CRC). CRC is divided in heritable and sporadic types, both mainly consisting of microsatellite unstable (MIN, 15%) and CIN (85%) tumors (Dunican et al., 2002a) . CIN correlates with poor patient prognosis: a meta-analysis of 63 studies with a total of 10.126 CRC patients (60% aneuploid tumors, as a proxy for CIN) showed that CIN tumors responded worse than non-CIN tumors to 5-Fluoruracil treatment, and (progression free) survival was decreased in CIN patients (Walther et al., 2008 ).
Despite the correlations described above, the roles of CIN and aneuploidy in tumor formation have not unequivocally emerged from animal studies and are thus still unclear.
Mouse models of CIN have occasionally shown sporadic, spontaneous tumors with very long latency (>12-18 months), and predominantly in spleen and lung (Diaz-Rodríguez et al., 2008; Iwanaga et al., 2007; Jeganathan et al., 2007; Li et al., 2009; Michel et al., 2001; Ricke et al., 2011; Sotillo et al., 2007; van Ree et al., 2010; Weaver et al., 2007) , suggesting CIN is not a potent cancer driver. In mice predisposed to cancer, CIN is either neutral (Baker et al., 2009b; Kalitsis et al., 2005; Silk et al., 2013) , promotes tumor formation (Babu et al., 2003; Baker et al., 2009b; Chi et al., 2009; Dai et al., 2004; Jeganathan et al., 2007; Rao et al., 2005; Ricke et al., 2011; van Ree et al., 2010; Zasadil et al., 2016) , or, in some conditions, suppresses it (Baker et al., 2009b; Silk et al., 2013; Weaver et al., 2007; Zasadil et al., 2016) . This may be related to differences in CIN levels reached in the various conditions, as high CIN levels can cause cell death and might thereby lead to tumor suppression (Funk et al., 2016) .
Comparisons between these studies is however exceedingly difficult due to the use of different oncogenic backgrounds, to differences in tissues that were examined, and to the manner and time by which the tissues were exposed to CIN. Moreover, technical limitations often precluded direct measurements of CIN in the relevant tissues. We therefore established a genetic mouse model that allows controlled induction of various degrees of CIN in a tissuespecific manner. With this model, we made direct comparisons and found striking, and tissuetype-depending, differences in the consequences for tumorigenesis between the various degrees of CIN.
RESULTS

An allelic series for graded increases of CIN in vivo
To enable tissue-specific induction of a range of CIN levels, we created mouse strains carrying a conditional T649A or D637A mutation in the spindle assembly checkpoint kinase Mps1.
These mutations in human cell lines caused mild or severe CIN, respectively (Jelluma et al., 2008) (Fig. 1A , B, S1A-C). We reasoned that combining these Cre-inducible Mps1 knock-in (CiMKi) alleles (together and with wild-type Mps1) would result in an allelic series of CIN, ranging from very low (few missegregations with mostly mild errors) to very high (many missegregations with mostly severe errors).
CiMKi mice were born healthy and at Mendelian ratios. Activation of Cre recombinase by addition of 4-hydroxytamoxifen (4-OHT) to mouse embryonic fibroblasts (MEFs) from CiMKi;Rosa26-CreER T2 mice resulted in efficient recombination and expression of mutant Mps1 mRNA (Fig. S1D) , from which mutant Mps1 protein was translated to comparable levels as wild-type protein (Fig. S1E ). As expected, the allelic series caused graded reductions in Mps1 activity, as evidenced by acceleration of mitosis after mutant induction (Sliedrecht et al., 2010) (Fig. 1C ) and reduced Mad1 levels at kinetochores (Lan and Cleveland, 2010) (Fig.   S1F ). Time-lapse microscopy of 4-OHT-treated immortalized MEFs showed a striking increase in mitotic errors with diminishing Mps1 kinase activities (Fig. 1D , Movies S1), verifying the predicted phenotypes of the allelic series. As expected, induced CIN resulted in increased aneuploidy in primary MEFs (Fig. S1G ). Mutant induction also occurred efficiently in vivo in four-week old CiMKi;Rosa26-CreRT2 mice (Fig. S1H) , and analysis of anaphase figures in intestinal tissue sections showed that the expected range of CIN was induced (Fig.   1E ). We thus conclude that the CiMKi mouse model enables spatio-temporal control of a range of CIN in vivo.
Moderate CIN causes early onset spontaneous tumorigenesis in the intestine
Whole-body mutant inductions in CiMKi;Rosa26-CreER T2 mice disrupted small intestinal tissue organization ( Fig. 2A) . The extent of disorganization correlated with the degree of CIN and likely explained the severe weight loss seen in mice with high and very high CIN (Fig.   S2A ). To study early CIN induction in the intestine without adverse effects on other organs, we generated CiMKi;Villin-Cre mice to enable mutant induction specifically in the intestinal tract from 12.5 days post coitum (dpc) (El Marjou et al., 2004) . Although all CiMKi;Villin-Cre mice were overtly healthy ( Fig. S2B) , moderate CIN had caused one or more adenomas in the small intestine of two-thirds (4/6) of the mice by as early as 12 weeks of age (Fig. 2B, C ).
These adenomas were positive for nuclear b-catenin, showing that CIN was sufficient to induce constitutive Wnt pathway activation (Fig. 2D ). To our knowledge, this is the first report of early onset, spontaneous tumorigenesis as a result of CIN. By the age of eight months, a wider range of CIN had caused increases in spontaneous adenomas (Fig. 2E, F ), further underscoring a role for CIN in tumor initiation.
In line with what we observed at 12 weeks, the strongest effect was again found in mice with moderate CIN.
Degree and site define oncogenic potential of CIN in tumor-prone intestines
Human colorectal cancers (CRCs) are often aneuploid (Cancer Genome Atlas, 2012) , and the vast majority is caused by loss-of-function mutations in genes of Wnt pathway components such as APC (Fearon and Vogelstein, 1989; Fodde et al., 2001; Powell et al., 1992) . Moreover, loss of heterozygosity (LOH) of APC causes extensive polyp growths in patients with familial adenomatous polyposis coli (FAP) syndrome (Ichii et al., 1993; Leoz et al., 2015; Miyaki et al., 1990) . To examine the impact of CIN on a tissue predisposed to cancer, we next investigated mice carrying a mutant Apc allele (Apc Min/+ ). These mice normally develop ±30 adenomas in the small intestine and no or very few in the colon (Jackstadt and Sansom, 2016) .
Note that the expected degrees of CIN in this tissue in CiMKi mice were directly verified by in situ analyses (see Fig. 1E (Baker et al., 2009b; Moser et al., 1990; Rao et al., 2005) , mice with moderate or high CIN had to be sacrificed at 6-8 weeks due to severe weight loss. Apc Min/+ mice with moderate CIN presented with a striking increase in the amount of small intestinal adenomas ( Fig. 3A -C, S3A).
Neither high nor low CIN, however, increased tumorigenesis, suggesting that tumor formation in the small intestine is sensitive to a narrow range of CIN.
Macroscopic examination of the colons of the same CiMKi;Apc Min/+ ;Villin-Cre mice revealed that in contrast to control and low CIN mice, colons from moderate and high CIN mice were widely covered with large adenomas (Fig. 3D-F, S3D ). This was most striking in the distal region of the colon, where aneuploid APC-mutant tumors also most frequently occur in humans (Kinzler and Vogelstein, 1996; Liu et al., 2018) . Tumor incidence was 100% (Fig.   S3G ), and the number of tumors was substantially higher than reported for other CIN models in the Apc Min/+ background (Baker et al., 2009b; Rao et al., 2005; Zasadil et al., 2016) .
Importantly, CIN in organoids established from these colon adenomas still corresponded to the expected levels (Fig. 3G , Movies S2), suggesting that high CIN levels were not selected against after tumor initiation and that there was no drift towards an 'optimal' CIN level. Of note: while individual tumor sizes were comparable between all induced CIN levels ( Fig. S3B , C, E, F), tumors with moderate or high CIN level had reached this size substantially earlier (6-8 vs. 12 weeks). We thus hypothesize that CIN advanced tumor initiation, accelerated tumor growth, or both.
In humans, tumors in the distal part of the colon are often considered CIN as they are typically aneuploid and karyotypically heterogeneous (De Sousa E Melo et al., 2013; Dunican et al., 2002b (Fig. 3G, H) . Chromosome 18, which harbors the Apc allele (that is often subject to LOH in human FAP tumors (Fearon and Vogelstein, 1989; Jackstadt and Sansom, 2016) ), was diploid in the vast majority of cells. Since tumor initiation in Apc Min/+ mice requires LOH of wild-type Apc (Luongo et al., 1994) and since CiMKi colon tumor organoids grew independently of Wnt ligands, this indicated that LOH of Apc by CIN occurred in a manner other than whole chromosome 18 loss, as previously suggested (Baker et al., 2009b) . Targeted PCR detected only Apc Min alleles ( Fig. S3H ), strongly suggesting that LOH was accomplished either by double non-disjunction events of both chromosomes 18 or by somatic recombination (Baker et al., 2009a; Haigis and Dove, 2003) , the latter of which is likely the cause of Apc LOH in FAP patients (Miyaki et al., 1990; Sieber et al., 2002) . Both these processes could be accelerated by CIN.
Colonic crypts retain proliferating CIN cells more readily than small intestinal crypts
Our data thus far show that the effect of CIN on karyotype heterogeneity and tumor formation 
DISCUSSION
Aneuploidy and CIN are hallmarks of cancer, yet despite impressive efforts to model CIN in tumorigenesis, its importance to tumor development remained unclear. Our new mammalian model for inducible, graded CIN levels, combined with direct visualization of chromosome segregation error frequencies in the relevant tissues allowed us to show that 1) moderate to high CIN levels are sufficient to drive tumor formation at early age, 2) the maximum effect on tumorigenesis is achieved by distinct CIN levels, and 3) this differs between tissues with an identical cancer predisposition mutation.
Although previous studies have reported spontaneous tumor formation in CIN mice, it occurred sporadically and with late onsets of more than 12 months of age (Diaz-Rodríguez et al., 2008; Iwanaga et al., 2007; Jeganathan et al., 2007; Li et al., 2009; Michel et al., 2001; Ricke et al., 2011; Sotillo et al., 2007; van Ree et al., 2010; Weaver et al., 2007) . By contrast, our CiMKi mice with moderate CIN (TA/TA) developed a substantial number of lesions in the small intestine as early as 12 weeks of age. This shows that CIN is a more potent driver of tumorigenesis than previously thought. As our model was able to probe the effects of a wide range of CIN, it is possible that the optimal CIN level for tumor induction was not reached in prior studies. The inducible nature of the CiMKi model is most probably a prerequisite for reaching the higher CIN levels. Many other CIN models were not inducible or tissue-specific, resulting in embryonic lethality in homozygous knock-outs, probably due to severe missegregations during the developmental stages (Dobles et al., 2000; Iwanaga et al., 2007; Jeganathan et al., 2007; Kalitsis et al., 2000; Wang et al., 2004) . Also, we used the CiMKi model here to induce CIN locally in the gastro-intestinal tract, thereby preventing adverse effects in other tissues.
Our model enabled us to directly compare the effects of the various CIN levels between two different tissues -small intestine and colon-within the same mice. Whereas in the Apc Min/+ background moderate CIN levels markedly increased tumor burdens in both tissues, high CIN levels only did so in the colon. There might be several explanations for this difference: our finding that moderate and high CIN leads to an enhanced proliferative state in colon but not in small intestine shows a remarkable difference in response between the two tissues. Enhanced proliferation can increase the chance that transformed cells propagate in colonic crypts (Nowak et al., 2002) , however it does not account for the tumorigenic effect of moderate CIN in the small intestine. Therefore, other factors might play a role as well, such as the normal variations throughout the gut in stem cell number and physiological Wnt activity (Leedham et al., 2013) or in the adaptive immune landscape (Agace and McCoy, 2017) . It will be exciting to further investigate the underlying mechanisms, as it can impact on future treatment strategies for different cancer types. The tissue-specific inducible nature of the CiMKi model enables studying the impact of various CIN levels in many other organs as well.
Apc
Min/+ mice (Moser et al., 1990; Moser et al., 1995) have been widely used to model human FAP, the hereditable form of CRC (Leoz et al., 2015) . Tumorigenesis in these mice (Baran et al., 2018) . Also, in contrast to tumors from Apc Min/+ mice (Luongo et al., 1994) , LOH in CiMKi;Apc Min/+ mice did not occur by loss of (part of) the wild-type allele. Instead, we found disomy of the mutant chromosome 18 in the tumors, similar to a CIN model driven by Bub1 insufficiency (Baker et al., 2009b) . Other processes by which LOH can be achieved are somatic recombination events (Haigis and Dove, 2003) , as was described for APC LOH in human FAP tumors (Miyaki et al., 1990; Sieber et al., 2002) , or double non-disjunction events during mitosis (Baker et al., 2009b) . CIN can be involved in both processes: DNA damage and double strand breaks as a result of CIN may be repaired through recombination with the mutant allele, and doubling of the mutant chromosome accompanied or followed by loss of the wild-type allele by non- 
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To induce loxP recombination, MEFs were treated with 4-hydroxy-tamoxifen (4-OHT; 1µM, Sigma H6278). Mice were injected intraperitoneally with Tamoxifen (1 mg dissolved in corn oil; Sigma, C8267). In CiMKi;Apc Min ;Villin-Cre mice, CiMKi alleles were induced at 12.5 dpc.
when the Villin promotor is activated. To confirm recombination, RNA was isolated with a quick RNA kit (Zymo Research). cDNA was prepared using standard procedures, subjected to PCR and subsequently sequenced to determine the presence of T649A or D637A. For primers see Table 1 , supplementary information.
Mice were sacrificed at four weeks, twelve weeks or eight months of age, and immediately dissected. small intestine was separated from colon, both were flushed with PBS and pieces of tissue were snap-frozen for later RNA/protein analysis. The organs were stored in formalin until further processing.
Histology and Immunohistochemistry
Formalin fixed intestines were cut open longitudinally and stained with 0.25% methylene blue in dH20, and rinsed with PBS. Pictures were taken with 6.3x magnification using an Olympus SZX stereo microscope to count the number of lesions in the small intestine and colon. After washing with PBS to remove the methylene blue, intestines were rolled into "Swiss rolls" for paraffin embedding.
For identification and assessment of tumors 4-μm sections of paraffin-embedded tissue were cut and stained with hematoxylin/eosin (H&E). These slides were scanned (Nanozoomer XR, Hamamatsu) for digital image analysis. Grading of dysplasias was done following the existing guidelines for human intestinal adenomas.
Apoptotic bodies were recognized on H&E stained sections, according to strict morphological criteria such as cell shrinkage with retracted pink to orange cytoplasm, chromatin condensation and nuclear fragmentation and separation of cells by a halo from adjacent enterocytes.
For proliferation measurements slides were incubated with Ki-67 antibody (ThermoFisher, 
MEFs (isolation, immunofluorescence, mitotic spreads, Western blot, and live microscopy)
CiMKi mice were bred with R26-CreER T2 mice and maintained in a stable homozygous CreER T2 background. Pregnant females were sacrificed at 13-17 dpc. by cervical dislocation.
Uterine horns were dissected out and placed in tubes containing PBS. Embryos were separated from their placenta and surrounding membranes. Red organs, brains and tail (for genotyping)
were removed. Embryos were finely minced using razor blades and the remaining cells/tissues were suspended in a tube containing 2 ml Trypsin and kept at 37°C for 15 minutes. Two volumes of media (DMEM supplemented with 10% FBS, non-essential amino acids, glutamin and Pen/Strep) were added and remaining tissues were removed by allowing them to settle down at the bottom of the tube. Supernatant was subjected to centrifugation for 5 minutes at 1000 rpm, cell pellet was resuspended in medium and plated in 10 cm dishes.
For immunofluorescence cells were plated on 12mm coverslips and harvested after one hour nocodazole (250 ng/ml, Sigma, M1404) and MG132 (2 µM, Sigma C2211) treatment. Cells were pre-extracted with 0.1% Triton X-100 in PEM (100 mM PIPES (pH 6.8), 1 mM MgCl2 and 5 mM EGTA) for one minute at 37°C before fixation with 4% paraformaldehyde in PBS.
Coverslips were subjected to antibody staining following standard procedures (primary antibodies anti-Mad1 (Santa Cruz sc67337, 1:1000), anti-Centromere Protein (ACA) (Antibodies Incorporated 15-234-0001, 1:2000) . Images were acquired on a DeltaVision RT system (Applied Precision) with a ×100/1.40NA UPlanSApo objective (Olympus) using SoftWorx software. Images are maximum intensity projections of deconvolved stacks.
Quantifications were done using ImageJ software and a macro to threshold and specifically select kinetochores as described previously (Saurin et al., 2011) .
For mitotic spreads, MEFs were treated with STLC (1 µM, Sigma 164739) for 4 hours. Mitotic cells (isolated by shake-off) were treated for 10 minutes in hypotonic buffer (75 mM KCl), fixed with acetic acid/methanol, dropped onto glass cover slides and stained with DAPI (1mg/ml, Sigma 32670). Images were acquired on a DeltaVision RT system (Applied Precision) with a ×100/1.40NA UPlanSApo objective (Olympus) using SoftWorx software.
Chromosomes were counted manually using Image J software.
For Western blot, MEFs were treated with 4-OHT or EtOH for 72 hours, and then lysed with Laemmli buffer. Protein levels were assessed by standard Western blot procedures (anti-ESK (Santa Cruz sc-541, 1:1000), and anti--Tubulin (Sigma T5168; 1:10000)).
For live cell imaging, immortalized MEFs (transduced with large T and small T expressing lentivirus (Plasmid #22298, Addgene) were transduced with an H2B-Neon expressing lentivirus (pLV-H2B-Neon-ires-Puromycin) Shaner et al., 2013) , and selected with puromycin (1µg/ml, Sigma P7255). These stably H2B-mNeon expressing MEFs were plated in 24-well plates and imaged 56 hours after 4-OHT treatment for sixteen hours in a heated chamber (37°C and 5% CO2) using a ×20/0.5NA UPLFLN objective on an Olympus IX-81 microscope, controlled by Cell-M software (Olympus). Images were acquired using a Hamamatsu ORCA-ER camera and processed using Cell-M and ImageJ software.
Organoids (isolation, culture and live microscopy)
Organoids were isolated from CiMKi;Apc Min/+ ;VillinCre(ERT2) mice as described previously (Sato et al., 2009) . In brief, intestines of six-to-twelve weeks-old mice were dissected and cleaned with PBS. They were incubated in 0.5mM EDTA on ice for 30 minutes (normal tissue), or EDTA treatment followed by 45 minutes in DMEM 2% FBS 1% Pen/Strep supplemented with 75u/ml collagenase and 125 µg/ml Dispase (tumor tissue). Intestines were put in tubes with PSB, and crypts were removed from their niche by harsh shaking. After filtering the suspension using a 70 µm strainer, crypts or tumor cells were seeded in Matrigel (Corning, stored at -20°C until further processing. Cell lysis was performed overnight at 50 °C using 0.05 units of Qiagen Protease in 1x NEB buffer 4 (NEB) followed by heat inactivation at 75 °C for 20 min and 80 °C for 5 min. The genomic DNA was subsequently fragmented with 100 nl 1 U NlaIII (NEB) in 1x Cutsmart (NEB) for 60 min at 37°C followed by heat inactivation at 80 °C for 20 min. 100 nl of 1 μM barcoded double-stranded NLAIII adapters and 100 nl of 40 U T4
DNA ligase (NEB) in 1x T4 DNA Ligase buffer (NEB) supplemented with 3mM ATP (Invitrogen) was added to each well and ligated overnight at 16 °C. After ligation samples were pooled and library preparation was performed as described previously (Muraro et al., 2016) 58 .
Libraries were sequenced on an Illumina Nextseq 500 with 1 x 75 bp single-end sequencing.
The fastq files were mapped to GRCH38 using the Burrows-Wheeler Aligner. The mapped data was further analyzed using custom scripts in Python, which parsed for library barcodes, removed reads without a NlaIII sequence and removed PCR-duplicated reads. Copy number analysis was performed as described previously (Bakker et al., 2016) .
Statistical analysis
Power analysis predicted the number of animals that had to be used in each group to detect differences with 80% power and 95% confidence. Animals were not randomized, but assigned to the experimental groups based on their genotype. Statistical analyses were done with GraphPad Prism software. Comparisons between CiMKi wildtype and CiMKi mutants were analyzed with one-tailed student's t-tests. Data is presented as mean ± SD unless otherwise stated in legends.
